Lv6
2260 积分 2022-06-17 加入
Oral Muvalaplin for Lowering of Lipoprotein(a) A Randomized Clinical Trial
13天前
已完结
BRAF — a tumour-agnostic drug target with lineage-specific dependencies
17天前
已完结
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
1个月前
已完结
Chapter Five - Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies
1个月前
已完结
The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases
7个月前
已完结
JAK inhibitor selectivity: new opportunities, better drugs?
7个月前
已完结
Targeting KRAS in cancer
10个月前
已完结
Type 2 diabetes
11个月前
已完结
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
1年前
已完结
PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial
1年前
已完结
Cosmetic use of Botulinum A exotoxin
皖公网安备34019202002308
